Avita Medical
Avita Medical Inc. is a regenerative medicine company specializing in therapeutic skin restoration. Their flagship product, the RECELL System, is FDA-approved for treating thermal burn wounds and full-thickness skin defects. The company leverages patient-derived skin cells to enhance healing and accelerate recovery, positioning itself as a leader in acute wound care solutions.
Short position
Avita Medical (ASX:AVH) has 0.12% of its shares on issue reported as short positions as of 5 Oct 2026, or about 88,026 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has fallen 0.14 percentage points. Its highest recorded short interest was 10.06% in November 2020. AVH is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4AVH community
Research Threads
Bull, bear, catalyst, and news-reaction posts tied directly to AVH.
Start the first AVH research thread
Anchor the conversation with a thesis, a catalyst, or a question worth debating.